{"SLR NAME":"Pulmonary embolism and venous thromboembolism in COVID-19: a systematic review and meta-analysis","References":[{"title1":"Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels","References":[{"title2":"Findings of Acute Pulmonary Embolism in COVID-19 Patients","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","References":[{"title3":"Coronavirus disease 2019 (COVID-19) Situation Report-23"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"}]},{"title2":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Novel coronavirus:China"},{"title3":"Coronavirus disease (COVID-19) outbreak"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel coronavirus:Thailand (ex-China)"},{"title3":"Novel coronavirus:Japan (ex-China)"},{"title3":"Novel coronavirus:Republic of Korea (ex-China)"},{"title3":"First travel-related case of 2019 novel coronavirus detected in United States"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China"},{"title3":"Clinical features and factors associated with outcomes of patients infected with a novel influenza A (H7N9) virus: a preliminary study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Clinical and imaging findings in patients with severe acute respiratory syndrome"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"The radiologic manifestations of H5N1 avian influenza"},{"title3":"Organizing pneumonia: perilobular pattern at thin-section CT"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias"}]},{"title2":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*","References":[]},{"title2":"Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients","References":[{"title3":"Massive pulmonary embolism"},{"title3":"Long-term complications of medical patients with hospital-acquired venous thromboembolism"},{"title3":"The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study"},{"title3":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis"},{"title3":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis"},{"title3":"A prospective study of risk factors for pulmonary embolism in women"},{"title3":"An association between atherosclerosis and venous thrombosis"},{"title3":"The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction"},{"title3":"Incidence of venous thromboembolism in patients hospitalized with cancer"},{"title3":"Clinical practice: combination estrogen-progestin oral contraceptives"},{"title3":"Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis"},{"title3":"Risk of thromboembolism varies, depending on category of immobility in outpatients"},{"title3":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry"},{"title3":"Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism"},{"title3":"Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism"},{"title3":"Prospective multicenter evaluation of the pulmonary embolism rule-out criteria"},{"title3":"Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism"},{"title3":"Accuracy of emergency physician-performed ultrasonography in the diagnosis of deepvein thrombosis: a systematic review and meta-analysis"},{"title3":"Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms"},{"title3":"Potential impact of adjusting the threshold of the quantitative D-dimer based on pretest probability of acute pulmonary embolism"},{"title3":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study"},{"title3":"CT venography and compression sonography are diagnostically equivalent: data from PIOPED II"},{"title3":"Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography"},{"title3":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report"},{"title3":"Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography"},{"title3":"Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study"},{"title3":"The acutely decompensated right ventricle: pathways for diagnosis and management"},{"title3":"Prognostic value of troponins in acute pulmonary embolism: a meta-analysis"},{"title3":"Factors associated with clinical deterioration shortly after PE"},{"title3":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis"},{"title3":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer"},{"title3":"Fibrinolysis for patients with intermediate-risk pulmonary embolism"},{"title3":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial"},{"title3":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism"},{"title3":"Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques"},{"title3":"Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach"},{"title3":"The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism"},{"title3":"A Multidisciplinary Pulmonary Embolism Response Team (PERT): initial 30-month experience with a novel approach to delivery of care to patients with sub-massive and massive PE"}]},{"title2":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. 2020. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspectedhuman-cases-20200117."},{"title3":"The fifth revised trial version of the novel coronavirus pneumonia diagnosis and treatment guidance. http://www.nhc.gov.cn/yzygj/s7652m/202002/41c3142b38b84ec4a748e60773cf9d4f.shtml"},{"title3":"Novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan"},{"title3":"Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Interactions between coagulation and inflammation"},{"title3":"Bidirectional relation between inflammation and coagulation"},{"title3":"Crosstalk between inflammation and coagulation: the lessons of sepsis"},{"title3":"Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan"},{"title3":"Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection"}]},{"title2":"Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded","References":[]}]},{"title1":"Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography","References":[{"title2":"Acute pulmonary embolism and COVID-19 pneumonia: a random association","References":[]},{"title2":"COVID-19 Complicated by Acute Pulmonary Embolism","References":[{"title3":"Characteristics of SARS-CoV-2 and COVID-19"},{"title3":"Thrombotic complications of COVID-19"},{"title3":"The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management"},{"title3":"COVID-19 and venous thromboembolism: A meta-analysis of literature studies"},{"title3":"Incidence of venous thromboembolism in hospitalized patients with COVID-19"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients"},{"title3":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health"},{"title3":"Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis"},{"title3":"The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC 2019. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)"},{"title3":"Interventional therapies for acute pulmonary embolism: Current status and principles for the development of novel evidence: A scientific statement from the American heart association"},{"title3":"Percutaneous aspiration thrombectomy in treatment of massive pulmonary embolism"},{"title3":"Current endovascular treatment options in acute pulmonary embolism"},{"title3":"Percutaneous thrombus removal in COVID-19-infected patient with pulmonary embolism"},{"title3":"COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy"}]},{"title2":"Review: Viral infections and mechanisms of thrombosis and bleeding","References":[{"title3":"Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: Report of 2 cases and literature review"},{"title3":"Hematemesis in a 2009 H1N1 influenza patient"},{"title3":"Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection"},{"title3":"H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13"},{"title3":"A case of haemorrhagic fever with renal syndrome complicated by spleen haemorrhage"},{"title3":"Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections"},{"title3":"Gastrointestinal bleeding with influenza virus"},{"title3":"Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression"},{"title3":"Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human parvovirus B19 infection"},{"title3":"Antiphospholipid antibodies and the antiphospholipid syndrome: Clinical significance and treatment"},{"title3":"Deep vein thrombosis and acute cytomegalovirus infection: Case report and review of the literature"},{"title3":"HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: An observational study"},{"title3":"Two cases of congenital cytomegalovirus infection associated with disseminated intravascular coagulation"},{"title3":"Acquired protein S deficiency: Correlation with advanced disease in HIV-1-infected patients"},{"title3":"Procoagulant and inflammatory response of virus-infected monocytes"},{"title3":"Pathogenesis of viral hemorrhagic fever"},{"title3":"Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus"},{"title3":"Pandemic H1N1 influenza infection and vascular thrombosis"},{"title3":"Pathology of the swine-origin influenza A (H1N1) flu"},{"title3":"A case of purpura fulminans secondary to transient protein C deficiency as a complication of chickenpox infection"},{"title3":"Junin virus infection of guinea pigs: Immunohistochemical and ultrastructural studies of hemopoietic tissue"},{"title3":"Haemolytic-uraemic syndrome with thrombotic microangiopathy of the retina following cytomegalovirus infection: Postmortem findings"},{"title3":"Antiphospholipid syndrome associated with infections: Clinical and microbiological characteristics"},{"title3":"Clinical and laboratory features of Crimean-Congo hemorrhagic fever: Predictors of fatality"},{"title3":"The effects of HIV infection on endothelial function"},{"title3":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: Challenges in determining a SARS diagnosis"},{"title3":"Unique selective right atrial hemorrhage with epidemic (Korean) hemorrhagic fever Am"},{"title3":"Parvovirus B19 associated adult Henoch Schonlein purpura"},{"title3":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus"},{"title3":"Thrombocytopenic purpura as a manifestation of acute hepatitis A"},{"title3":"Seasonal changes in platelets, fibrinogen and factor VII in elderly people"},{"title3":"Review: Thromboses among HIV-infected patients during the highly active antiretroviral therapy era"},{"title3":"A plasma inhibitor of platelet aggregation in patients with Lassa fever"},{"title3":"Blood coagulation and its regulation by anticoagulant pathways: Genetic pathogenesis of bleeding and thrombotic diseases"},{"title3":"The procoagulant response of cytomegalovirus infected endothelial cells"},{"title3":"Intravascular coagulation complicating influenza A virus infection"},{"title3":"Acute cytomegalovirus infection and venous thrombosis: Role of antiphospholipid antibodies"},{"title3":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock 2008"},{"title3":"Mechanisms for increment of platelet associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease"},{"title3":"Severe thrombocytopenia and response to corticosteroids in a case of nephropathia epidemica"},{"title3":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines"},{"title3":"Acquired protein C and protein S deficiency in HIV-infected patients"},{"title3":"Autoimmune complications associated with hepatitis A virus infection in children"},{"title3":"The impact of the inflammatory response on coagulation"},{"title3":"Morbidity and mortality in the catastrophic antiphospholipid syndrome: Pathophysiology, causes of death, and prognostic factors"},{"title3":"Thrombotic tendencies and correlation with clinical status in patients infected with HIV"},{"title3":"Association between cytomegalovirus infection and venous thromboembolism"},{"title3":"Class of antiretroviral drugs and the risk of myocardial infarction"},{"title3":"Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects"},{"title3":"Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells"},{"title3":"Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration Arch"},{"title3":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)"},{"title3":"Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses"},{"title3":"Exotic emerging viral diseases: Progress and challenges"},{"title3":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: A study in rhesus monkeys"},{"title3":"Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event"},{"title3":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells"},{"title3":"Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo"},{"title3":"Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage"},{"title3":"The significance of auto-antibodies against beta2-Glycoprotein I"},{"title3":"Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus"},{"title3":"High prevalence of anticardiolipin antibodies in hepatitis C virus infection: Lack of effects on thrombocytopenia and thrombotic complications"},{"title3":"Autopsy findings in eight patients with fatal H1N1 influenza"},{"title3":"The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates"},{"title3":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever"},{"title3":"Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections"},{"title3":"Activation of coagulation and fibrinolysis during dengue virus infection"},{"title3":"Crosstalk between coagulation and inflammation during Dengue virus infection"},{"title3":"Blood coagulation disorders during primary cytomegalovirus infection"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Case report: Cytomegalovirus infection as a cause of acute portal vein thrombosis"},{"title3":"Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells"},{"title3":"A global perspective on hantavirus ecology, epidemiology, and disease"},{"title3":"The varicella-autoantibody syndrome"},{"title3":"Protein S declines during winter respiratory infections"},{"title3":"Detection of anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP) and in patients with rubella and herpes group viral infections"},{"title3":"Relapse of idiopathic thrombocytopenic purpura caused by influenza A virus infection: A case report"},{"title3":"Thrombopoietin"},{"title3":"Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum"},{"title3":"Cytomegalovirus-associated bleeding diathesis in renal transplant recipients"},{"title3":"Infections and endothelial cells"},{"title3":"Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1"},{"title3":"Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins"},{"title3":"Hantaviruses: Molecular biology, evolution and pathogenesis"},{"title3":"Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression"},{"title3":"Is chronic HIV infection associated with venous thrombotic disease? A systematic review"},{"title3":"Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy"},{"title3":"Basic clinical and laboratory features of filoviral hemorrhagic feverJ"},{"title3":"Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans"},{"title3":"Hematologic side effects of interferon and ribavirin therapy"},{"title3":"Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis)"},{"title3":"The role of the vascular endothelium in arenavirus haemorrhagic fevers"},{"title3":"Lupus anticoagulant and protein S deficiency in a child who developed disseminated intravascular coagulation in association with varicella"},{"title3":"Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection"},{"title3":"Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection"},{"title3":"Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection"},{"title3":"Coagulopathy in patients with hemorrhagic fever with renal syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Disseminated intravascular coagulation"},{"title3":"Bidirectional relation between inflammation and coagulation"},{"title3":"New insights into pathways that determine the link between infection and thrombosis"},{"title3":"Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis"},{"title3":"Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line"},{"title3":"Mesenteric vein thrombosis associated with primary cytomegalovirus infection: A case report"},{"title3":"Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation"},{"title3":"Coagulation and inflammation. Molecular insights and diagnostic implications"},{"title3":"Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy"},{"title3":"Intensity of platelet beta(3) integrin in patients with hemorrhagic fever with renal syndrome and its correlation with disease severity"},{"title3":"Switch to high-level virus replication and HLA class I upregulation in differentiating megakaryocytic cells after infection with pathogenic hantavirus"},{"title3":"Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases"},{"title3":"Pathogenesis of filoviral haemorrhagic fevers"},{"title3":"Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence"},{"title3":"Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis"},{"title3":"Anticardiolipin antibodies in patients with liver disease"},{"title3":"Inflammation and coagulation in the cardiovascular system: The contribution of influenza"},{"title3":"The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis"},{"title3":"Dengue virus pathogenesis: An integrated view"},{"title3":"Viral hemorrhagic fevers"},{"title3":"Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus"},{"title3":"Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection"},{"title3":"Lung pathology in fatal novel human influenza A (H1N1) infection"},{"title3":"Varicella-associated thrombocytopenia: Autoantibodies against platelet surface glycoprotein V"},{"title3":"Herpes simplex and varicella-zoster: Comparative histopathology of 77 cases"},{"title3":"Hemorrhagic varicella: A case report and review of the complications of varicella in children"},{"title3":"Pathologic findings in novel influenza A (H1N1) virus (&quot;swine flu&quot;) infection: Contrasting clinical manifestations and lung pathology in two fatal cases"},{"title3":"Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens"},{"title3":"Thrombotic thrombocytopenic purpura and cytomegalovirus infection in an immunocompetent adult"},{"title3":"Herpesvirus in atherosclerosis and thrombosis: Etiologic agents or ubiquitous bystanders?"},{"title3":"Herpesviruses and thrombosis: Activation of coagulation on the endothelium"},{"title3":"Disseminated intravascular coagulation due to cytomegalovirus infection in an immunocompetent adult treated with plasma exchange"},{"title3":"Interactions between coagulation and inflammation"},{"title3":"Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance"},{"title3":"Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia"},{"title3":"Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis"},{"title3":"An overview of the mechanisms of HIV-related thrombocytopenia"},{"title3":"Hypopituitarism as a late complication of hemorrhagic fever"},{"title3":"Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology"},{"title3":"Inflammation and coagulation. An overview"},{"title3":"Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted"},{"title3":"Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection"},{"title3":"HIV-1 infection of human brain-derived microvascular endothelial cells in vitro"},{"title3":"Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome"},{"title3":"Prothrombinase assembly on an enveloped virus: Evidence that the cytomegalovirus surface contains procoagulant phospholipid"},{"title3":"Virus-associated idiopathic thrombocytopenic purpura"},{"title3":"Hematologic abnormalities associated with influenza A infection: A report of 3 cases"},{"title3":"Lassa fever: Epidemiology, clinical features, and social consequences"},{"title3":"Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils"},{"title3":"Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus"},{"title3":"Emerging roles of tissue factor in viral hemorrhagic fever"},{"title3":"Hughes syndrome crosses boundaries"},{"title3":"Influence of load of hepatitis A virus on disease severity and its relationship with clinical manifestations in patients with hepatitis A"},{"title3":"Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection"},{"title3":"Viral hemorrhagic fever:A vascular disease?"},{"title3":"Inflammation, endothelium, and coagulation in sepsis"},{"title3":"Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: A controlled laboratory study"},{"title3":"Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection"},{"title3":"Antiphospholipid antibodies, antiphospholipid syndrome and infections"},{"title3":"Acute cytomegalovirus infection complicated by venous thrombosis in a renal transplant recipient"},{"title3":"Petechial rash with pandemic influenza (H1N1) infection"},{"title3":"Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting"},{"title3":"Expression of ICAM-1 on the Hantaan virus-infected human umbilical vein endothelial cells"},{"title3":"Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever"},{"title3":"Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection"},{"title3":"Pathological changes associated with the 2009 H1N1 virus"},{"title3":"Effects of human cytomegalovirus infection on the coagulation system"},{"title3":"A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients"},{"title3":"Viral hepatitis and thrombosis: a narrative review Semin "},{"title3":"Pituitary hemorrhage as a complication of hantaviral disease"},{"title3":"Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness"},{"title3":"Coagulation initiated on herpesviruses"},{"title3":"Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1"},{"title3":"Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection"},{"title3":"Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia"},{"title3":"Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A"},{"title3":"Interaction of influenza virus with blood platelets"},{"title3":"Viral infections and antiphospholipid antibodies"},{"title3":"Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort"},{"title3":"The effect of inflammation on coagulation and vice versa"},{"title3":"Crosstalk between inflammation and coagulation: The lessons of sepsis"},{"title3":"Review: Infectious diseases and coagulation disorders"},{"title3":"Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever"},{"title3":"Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever"},{"title3":"Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection"},{"title3":"Postvaricella purpura fulminans caused by acquired protein S deficiency resulting from antiprotein S antibodies: Search for the epitopes"},{"title3":"Disseminated intravascular coagulation as an unusual presentation of an Epstein-Barr virus infection"},{"title3":"Hospitalized patients with 2009 H1N1 influenza infection: The Mayo Clinic experience"},{"title3":"Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis"},{"title3":"Hepatitis C virus, antiphospholipid antibodies, and thrombosis"},{"title3":"Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium"},{"title3":"Procoagulant activity of endothelial cells after infection with respiratory viruses"},{"title3":"Review article: The pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease"},{"title3":"Disseminated intravascular coagulation and acute renal failure in influenza A2 infection"},{"title3":"Coagulation abnormalities in dengue hemorrhagic fever: Serial investigations in 167 Vietnamese children with Dengue shock syndrome"},{"title3":"Hemostatic disorders in bird flu infection"},{"title3":"Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis"},{"title3":"Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease"},{"title3":"Human cytomegalovirus infection induces mRNA expression and secretion of plasminogen inhibitor type-1 in endothelial cells"},{"title3":"SARS in Hong Kong"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice"},{"title3":"Transient lupus anticoagulant induced by Epstein-Barr virus infection"},{"title3":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)"},{"title3":"Cytomegalovirus infection and thrombosis: A causative association?"},{"title3":"Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?"},{"title3":"Thrombomodulin expression of sinusoidal endothelial cells in chronic viral hepatitis"},{"title3":"Hemorrhagic fever caused by a novel Bunyavirus in China: Pathogenesis and correlates of fatal outcome"}]},{"title2":"Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA","References":[{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung Injury (EVALI): evolving knowledge and remaining questions"},{"title3":"Drug-induced lung disease: high-resolution CT findings"},{"title3":"Imaging of cancer immunotherapy: current approaches and future directions"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Acute pulmonary injury: high-resolution CT and histopathological spectrum"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Temporal Changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT findings in cases from the cruise ship &quot;Diamond Princess&quot; with coronavirus disease 2019 (COVID-19)"},{"title3":"Sensitivity of chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - The State of the Art"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Fleischner society: glossary of terms for thoracic imaging"}]}]},{"title1":"Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department","References":[{"title2":"Yang W, Sirajuddin A, Zhang X et al (2020) The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). Eur Radiol. 10.1007/s00330-020-06827-4","References":[]},{"title2":"Revel M-P, Parkar AP, Prosch H et al (2020) COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 10.1007/s00330-020-06865-y","References":[]},{"title2":"Ai T, Yang Z, Hou H et al (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 10.1148/radiol.2020200642","References":[]},{"title2":"Wen Z, Chi Y, Zhang L et al (2020) Coronavirus disease 2019: initial detection on chest CT in a retrospective multicenter study of 103 Chinese subjects. Radiology: Cardiothorac Imaging. 10.1148/ryct.2020200092","References":[]},{"title2":"Fang Y, Zhang H, Xie J et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 10.1148/radiol.20200200432","References":[]},{"title2":"Bai HX, Hsieh B, Xiong Z et al (2020) Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 10.1148/radiol.20200200823","References":[]},{"title2":"General Office of National Health Committee. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial revised fifth edition). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. Accessed 15 Apr 2020","References":[]},{"title2":"Yang R, Lo X, Liu H et al (2020) Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiology: Cardiothorac Imaging. 10.1148/ryct.2020200047","References":[]},{"title2":"Zhou Z, Guo D, Li C et al (2020) Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 10.1007/s00330-020-06816-7","References":[]},{"title2":"Li K, Fang Y, Li W et al (2020) CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 10.1007/s00330-020-06817-6","References":[]},{"title2":"Magro C, Mulvey JJ, Berlin D et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 10.1016/j.trsl.2020.04.007","References":[]},{"title2":"Ranucci M, Ballotta A, Di Dedda U et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 10.1111/jth.14854","References":[]},{"title2":"Danzi GB, Loffi M, Galeazzi G, Gherbesi E (2020) Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 10.1093/eurheartj/ehaa254","References":[]},{"title2":"Xie Y, Wang X, Yang P, Zhang S (2020) COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothorac Imaging. 10.1148/ryct.2020200067","References":[]},{"title2":"Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 10.1016/j.thromres.2020.04.013","References":[]},{"title2":"Leonard-Lorant I, Delabranche X, Severac F et al (2020) Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels. Radiology. 10.1148/radiol.2020201561","References":[]},{"title2":"Grillet F, Behr J, Calame P, Aubry S, Delabrousse E (2020) Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology. 10.1148/radiol.2020201544","References":[]},{"title2":"Chen J, Wang X, Zhang S et al (2020) Findings of acute pulmonary embolism in COVID-19 patients. Available at SSRN: https://ssrn.com/abstract=3548771 or 102139/ssrn3548771Google Scholar","References":[]},{"title2":"Incidence of transient interruption of contrast (TIC) - a retrospective single-centre analysis in CT pulmonary angiography exams acquired during inspiratory breath-hold with the breathing command: &quot;please inspire gently!&quot;","References":[{"title3":"CTPA as the gold standard for the diagnosis of pulmonary embolism"},{"title3":"Waiting to exhale: salvaging the nondiagnostic CT pulmonary angiogram by using expiratory imaging to improve contrast dynamics"},{"title3":"Contrast dynamics during CT pulmonary angiogram: analysis of an inspiration associated artifact"},{"title3":"Suspected pulmonary embolism: enhancement of pulmonary arteries at deep-inspiration CT angiography:influence of patent foramen ovale and atrial-septal defect"},{"title3":"Measurement of caval blood flow with MRI during respiratory maneuvers: implications for vascular contrast opacification on pulmonary CT angiographic studies"},{"title3":"Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol"},{"title3":"Transient interruption of contrast on CT pulmonary angiography: proof of mechanism"},{"title3":"Re: Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. A reply"},{"title3":"Suction/Inspiration against resistance or standardized Mueller maneuver: a new breathing technique to improve contrast density within the pulmonary artery: a pilot CT study"},{"title3":"Suction against resistance: a new breathing technique to significantly improve the blood flow ratio of the superior and inferior vena cava"},{"title3":"Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy"},{"title3":"Has &quot;respiratory coaching&quot; before deep inspiration an impact on the incidence of transient contrast interruption during pulmonary CT angiography?"},{"title3":"CT angiography for pulmonary embolism detection: the effect of breathing on pulmonary artery enhancement using a 64-row detector system"},{"title3":"Optimizing computed tomography pulmonary angiography using right atrium bolus monitoring combined with spontaneous respiration"},{"title3":"Feasibility of computed tomography pulmonary angiography with low flow rates"}]},{"title2":"Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging","References":[]},{"title2":"CT angiography of pulmonary embolism: diagnostic criteria and causes of misdiagnosis","References":[]},{"title2":"Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis","References":[]},{"title2":"Ng M-Y, Lee EYP, Yang J et al (2020) Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology: Cardiothorac Imaging. 10.1148/ryct.2020200034","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Casey K, Iteen A, Nicolini R, Auten J (2020) COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 10.1016/j.ajem.2020.04.011","References":[]},{"title2":"Zhao W, Zhong Z, Xie X, Yu Q, Liu J (2020) Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 10.2214/AJR.20.22976","References":[]},{"title2":"Lippi G, Favaloro EJ (2020) D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 10.1055/s-0040-1709650","References":[]},{"title2":"Han H, Yang L, Liu R et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 10.1515/cclm-2020-0188","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]}]},{"title1":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","References":[{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS,. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans [published online ahead of print 27 May 2020]. Lancet Respir Med. doi:10.1016/S2213-2600(20)30243-5.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. 2020. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspectedhuman-cases-20200117."},{"title3":"The fifth revised trial version of the novel coronavirus pneumonia diagnosis and treatment guidance. http://www.nhc.gov.cn/yzygj/s7652m/202002/41c3142b38b84ec4a748e60773cf9d4f.shtml"},{"title3":"Novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan"},{"title3":"Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Interactions between coagulation and inflammation"},{"title3":"Bidirectional relation between inflammation and coagulation"},{"title3":"Crosstalk between inflammation and coagulation: the lessons of sepsis"},{"title3":"Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan"},{"title3":"Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection"}]},{"title2":"Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [published online ahead of print 10 April 2020]. Thromb Res. doi:10.1016/j.thromres.2020.04.013.","References":[]},{"title2":"Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up [published online ahead of print 15 April 2020]. J Am Coll Cardiol. doi:10.1016/j.jacc.2020.04.031.","References":[]},{"title2":"Obi AT, Barnes GD, Wakefield TW, et al. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic [published online ahead of print 17 April 2020]. J Vasc Surg Venous Lymphat Disord. doi:10.1016/j.jvsv.2020.04.009.","References":[]},{"title2":"Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? [published online ahead of print 29 April 2020]. Thromb Haemost. doi:10.1055/s-0040-1712097.","References":[]},{"title2":"Reporting results of cancer treatment","References":[]},{"title2":"Platelet transfusion: a clinical practice guideline from the AABB","References":[]},{"title2":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","References":[]},{"title2":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City [published online ahead of print 17 April 2020]. N Engl J Med. doi:10.1056/NEJMc2010419.","References":[]},{"title2":"The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview","References":[]},{"title2":"D-dimer in acute medically ill adults and current thromboprophylaxis: a multicenter observational study evaluating the prevalence of elevated D-dimer in acute medically ill, hospitalized adults and current thromboprophylaxis trends; the DAMIACT Study, initial data analysis","References":[]},{"title2":"The perils of D-dimer in the medical intensive care unit","References":[]},{"title2":"D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients","References":[]},{"title2":"C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study","References":[{"title3":"Venous thrombosis: a multi-causal disease"},{"title3":"Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population"},{"title3":"Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population"},{"title3":"Inflammation in atherosclerosis: from pathophysiology to practice"},{"title3":"C-reactive protein and risk of venous thromboembolism in the general population"},{"title3":"Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation"},{"title3":"High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study"},{"title3":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)"},{"title3":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men"},{"title3":"Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)"},{"title3":"Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality-The Tromso Study"},{"title3":"Epidemiology of venous thromboembolism"},{"title3":"Cancer-related inflammation"},{"title3":"Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review"},{"title3":"Inflammation, obesity, and thrombosis"},{"title3":"Acute infections and venous thromboembolism"},{"title3":"Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting"},{"title3":"Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study"},{"title3":"The case-crossover design: a method for studying transient effects on the risk of acute events"},{"title3":"Inflammatory response in the acute phase of deep vein thrombosis"},{"title3":"Triggers of hospitalization for venous thromboembolism"},{"title3":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study"},{"title3":"Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study"},{"title3":"Innate immunity and coagulation"},{"title3":"Origin and physiological roles of inflammation"},{"title3":"Harmful molecular mechanisms in sepsis"},{"title3":"The impact of the inflammatory response on coagulation"},{"title3":"Molecular circuits in thrombosis and inflammation"},{"title3":"Neutrophil extracellular traps in immunity and disease"},{"title3":"Thrombosis: tangled up in NETs"},{"title3":"C-reactive protein: a critical update"},{"title3":"C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant"},{"title3":"C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction"},{"title3":"Direct proinflammatory effect of C-reactive protein on human endothelial cells"},{"title3":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection"}]},{"title2":"Persistent systemic inflammation is associated with bleeding risk in atrial fibrillation patients","References":[]},{"title2":"The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis","References":[{"title3":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)"},{"title3":"Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis"},{"title3":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial"},{"title3":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients"},{"title3":"Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy"},{"title3":"Deep vein thrombosis in intensive care"},{"title3":"VTE incidence and risk factors in patients with severe sepsis and septic shock"},{"title3":"Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study"},{"title3":"Risk assessment as a guide for the prevention of the many faces of venous thromboembolism"},{"title3":"Diagnosis of acute lower limb deep venous thrombosis with ultrasound: trends and controversies"},{"title3":"Short-term anticoagulant therapy and thrombus location are independent risk factors for delayed recanalization of deep vein thrombosis"},{"title3":"Safety of catheter-directed thrombolysis for the treatment of acute lower extremity deep vein thrombosis: a systematic review and meta-analysis"},{"title3":"Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis"},{"title3":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines"},{"title3":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines"},{"title3":"Venous thromboembolic events following major pelvic and abdominal surgeries for cancer: a prospective cohort study"},{"title3":"Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors"},{"title3":"Follow-up after four-year quality improvement program to prevent inferior limb deep vein thrombosis in intensive care unit"},{"title3":"Reduction in deep vein thrombosis incidence in intensive care after a clinician education program"},{"title3":"Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients"},{"title3":"Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care"},{"title3":"Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis"},{"title3":"Correlation of the caprini score and venous thromboembolism incidence following primary total joint arthroplasty-results of a single-institution protocol"},{"title3":"Prevention of VTE in nonorthopedic surgical patients"},{"title3":"A validation study of a retrospective venous thromboembolism risk scoring method"},{"title3":"The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients"},{"title3":"Deep vein thrombosis in medical and surgical intensive care unit patients in a tertiary care centre in North India: incidence and risk factors"},{"title3":"The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes"},{"title3":"Prevalence and predictors of deep vein thrombosis in critically Ill medical patients who underwent diagnostic duplex ultrasonography"},{"title3":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer"},{"title3":"Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial"},{"title3":"Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit"},{"title3":"Risk factors for hospital-associated venous thromboembolism in the neonatal intensive care unit"},{"title3":"Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: a prospective observational study"},{"title3":"Comparative thrombosis risk of vascular access devices among critically ill medical patients"},{"title3":"Deep vein thrombosis among intensive care unit patients; an epidemiologic study"}]},{"title2":"Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis","References":[]}]},{"title1":"High incidence of venous thromboembolic events in anticoagulated severe COVID?19 patients","References":[{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","References":[]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics"},{"title3":"Thrombocytopenia in critically ill patients receiving thromboprophylaxis"},{"title3":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis"},{"title3":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology"},{"title3":"Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)"},{"title3":"Sepsis definitions task force. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"},{"title3":"More than an anticoagulant: do heparins have direct anti-inflammatory effects?"}]},{"title2":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","References":[{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy"},{"title3":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients"},{"title3":"Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom"},{"title3":"Where do we stand with antithrombotic prophylaxis in patients with COVID-19?"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Thromboinflammation and the hypercoagulability of COVID-19"},{"title3":"Pulmonary embolism"}]},{"title2":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. 2020. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspectedhuman-cases-20200117."},{"title3":"The fifth revised trial version of the novel coronavirus pneumonia diagnosis and treatment guidance. http://www.nhc.gov.cn/yzygj/s7652m/202002/41c3142b38b84ec4a748e60773cf9d4f.shtml"},{"title3":"Novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan"},{"title3":"Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Interactions between coagulation and inflammation"},{"title3":"Bidirectional relation between inflammation and coagulation"},{"title3":"Crosstalk between inflammation and coagulation: the lessons of sepsis"},{"title3":"Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan"},{"title3":"Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection"}]}]}]}